PM&R
Volume 2, Issue 5 , Pages 359-363 , May 2010

Building a Measure of Fatigue: The Functional Assessment of Chronic Illness Therapy Fatigue Scale

  • Eleanor Smith, MD

      Affiliations

    • University of Chicago Pritzker School of Medicine, Chicago, IL⁎
    • ,
  • Jin-Shei Lai, PhD

      Affiliations

    • Northwestern University Feinberg School of Medicine, Evanston, IL†
    • ,
  • David Cella, PhD

      Affiliations

    • Northwestern University Feinberg School of Medicine, 633 Clark Street, Evanston, IL 60208‡
    • Corresponding Author InformationAddress correspondence to: D.C.

Received 1 February 2010 ,Accepted 20 April 2010.

References 

  1. World Health Organization. International Classification of Functioning, Disability and Health (ICF). Geneva, Switzerland: World Health Organization; 2001;
  2. Glaus A. Fatigue: an orphan topic in patients with cancer?. Eur J Cancer. 1998;34:1649–1651
  3. North American Nursing Diagnosis Association. Nursing Diagnoses: Definition and Classification, 1997-1998. Philadelphia, PA: McGraw-Hill; 1996;
  4. Leavitt VM, DeLuca J. Central Fatigue: Issues related to cognition, mood and behavior, and psychiatric dagnoses. PM&R. 2010;2:332–337
  5. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74
  6. Cella D, Zagari MJ, Vandoros C, Gagnon DD, Hurtz HJ, Nortier JW. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol. 2003;21:366–373
  7. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94:528–538
  8. Crane P, Gibbons L, Narasimhalu K, Lai JS, Cella D. Rapid detection of differential item functioning in assessments of health-related quality of life: the Functional Assessment of Cancer Therapy. Qual Life Res. 2007;16:101–114
  9. Hahn EA, Cella D, Dobrez DG, et al. The impact of literacy on health-related quality of life measurement and outcomes in cancer outpatients. Qual Life Res. 2007;16:495–507
  10. Hahn EA, Rao D, Cella D, Choi SW. Comparability of interview- and self-administration of the Functional Assessment of Cancer Therapy-General (FACT-G) in English- and Spanish-speaking ambulatory cancer patients. Med Care. 2008;46:423–431
  11. Mallinson T, Cella D, Cashy J, Holzner B. Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage. 2006;31:229–241
  12. Brown DJF, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2005;103:377–382
  13. Berndt E, Kallich J, McDermott A, Xu X, Lee H, Glaspy J. Reductions in anemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy. Pharmacoeconomics. 2005;23:505–514
  14. Dahele M, Skipworth RJ, Wall L, Voss A, Preston T, Fearon KC. Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J Pain. 2007;33:676–685
  15. Tyring S, Gottlieb A, Papp K, et al. Etanercept improves clinical outcomes, fatigue and symptoms of depression in subjects with psoriasis: results from a double-blind placebo-controlled, randomized phase 3 study. Lancet. 2006;367:29–35
  16. Cohen EE. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol. 2006;24:2659–2665
  17. Gladman DD, Mease PJ, Cifaldi MA, Perdok RJ, Sasso E, Medich J. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial. Ann Rheum Dis. 2007;66:163–168
  18. Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355(12):1233–1243
  19. Brucker PS, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28:192–211
  20. Lai JS, Cella D, Chang CH, Bode RK, Heinemann AW. Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res. 2003;12:485–501
  21. Fries JF, Bruce B, Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol. 2005;23:S33–S37
  22. Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap Cooperative Group during its first two years. Med Care. 2007;45(Suppl 1):S3–S11
  23. Cantor FK. Central and peripheral fatigue: Exemplified by multiple sclerosis and myasthenia gravis. PM&R. 2010;2:399–405

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

PII: S1934-1482(10)00337-0

doi: 10.1016/j.pmrj.2010.04.017

PM&R
Volume 2, Issue 5 , Pages 359-363 , May 2010

Article Tools